Search Within

Hematologic Malignancies Research

Formats
  1. Journal Article (1545)
  2. Meeting Abstract (1260)
  3. Review (76)
  4. Editorial (35)
  5. Book Section (32)
  6. Research Letter (26)
  7. Conference Paper (15)
  8. Correspondence (8)
  9. Guidelines (4)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3005)
  2. GSK Faculty (2450)
  3. Department of Medicine (2318)
  4. Hematologic Malignancies, Division of (2120)
  5. Sloan Kettering Institute Faculty (2052)
  6. Molecular Pharmacology and Chemistry Program Faculty (1632)

More Groups

People
  1. Michel Sadelain (586)
  2. David Scheinberg (502)
  3. Alexander Lesokhin (381)
  4. Carl Landgren (336)
  5. Renier Brentjens (286)
  6. Gabriela Chiosis (281)

More People

Years
  1. 2025 (64)
  2. 2024 (131)
  3. 2023 (175)
  4. 2022 (126)
  5. 2021 (154)
  6. 2020 (173)

More Years

Publications
  1. Blood (660)
  2. Cancer Research (117)
  3. Journal of Clinical Oncology (112)
  4. Clinical Lymphoma, Myeloma and Leukemia (84)
  5. Biology of Blood and Marrow Transplantation (80)
  6. Molecular Therapy (68)

More Publications

Publishers
  1. American Society of Hematology (700)
  2. Nature Publishing Group (375)
  3. Elsevier Inc. (291)
  4. American Association for Cancer Research (245)
  5. American Society of Clinical Oncology (116)
  6. Cell Press (116)

More Publishers

Results (3005)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
    Meeting Abstract

    Mondello, P.; Derenzini, E.; Asgari, Z.; Philip, J.; Brea, E. J.; Seshan, V. E.; Hendrickson, R.; de Stanchina, E.; Scheinberg, D. A.; Younes, A.
    Blood (2016)

    Fulltext@MSK | Save
  • Genetic alterations predict outcomes in patients with myelodysplastic syndrome receiving allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Lindsley, R. C.; Saber, W.; Mar, B. G.; Redd, R. A.; Haagenson, M. D.; Grauman, P. V.; Spellman, S. R.; Lee, S. J.; Wang, T.; Verneris, M. R.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Non-catalytic role of SETD1A regulates DNA repair in leukemia
    Meeting Abstract

    Hoshii, T.; Cifani, P.; Nakadai, T.; Feng, Z.; Huang, C. H.; Koche, R.; Delaney, C. D.; Chen, C. W. D.; Lowe, S. W.; Roeder, R.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Germline mutations in patients receiving unrelated donor hematopoietic cell transplant for severe aplastic anemia
    Meeting Abstract

    Gadalla, S. M.; Ballew, B. J.; Haagenson, M. D.; Spellman, S. R.; Hicks, B.; Alter, B. P.; Zhu, B.; Zhou, W.; Yeager, M.; Wang, T.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Donor telomere length and outcomes after allogeneic unrelated hematopoietic cell transplant in patients with acute leukemia
    Meeting Abstract

    Gadalla, S. M.; Wang, T.; Loftus, D.; Friedman, L.; Dagnall, C.; Haagenson, M. D.; Spellman, S. R.; Buturovic, L.; Blauwkamp, M.; Shelton, J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Implications of concurrent ibrutinib therapy on CAR T-cell manufacturing and phenotype and on clinical outcomes following CD19-targeted CAR T-cell administration in adults with relapsed/refractory CLL
    Meeting Abstract

    Geyer, M. B.; Park, J. H.; Riviere, I.; Senechal, B.; Wang, X.; Purdon, T. J.; Sadelain, M. W.; Brentjens, R. J.
    Blood (2016)

    Fulltext@MSK | Save
  • Aberrant phosphorylation of MEF2C is dispensable for hematopoiesis, and induces chemotherapy resistance and susceptibility to MARK kinase inhibition therapy in acute myeloid leukemia
    Meeting Abstract

    Brown, F. C.; Still, E.; Cifani, P.; Reed, C.; Ficarro, S.; He, J.; Koche, R.; Bhola, P.; Romanienko, P.; Mark, W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • IL-18 secreting CAR T cells enhance cell persistence, induce prolonged B cell aplasia and eradicate CD19+ tumor cells without need for prior conditioning
    Meeting Abstract

    Avanzi, M. P.; van Leeuwen, D. G.; Li, X.; Cheung, K.; Park, H.; Purdon, T. J.; Brentjens, R. J.
    Blood (2016)

    Fulltext@MSK | Save
  • Pembrolizumab in combination with pomalidomide and dexamethasone for relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Badros, A. Z.; Hyjek, E.; Ma, N.; Lesokhin, A. M.; Rapoport, A. P.; Kocoglu, M. H.; Lederer, E.; Philip, S.; Lesho, P.; Johnson, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Ribosomal protein Rpl22 regulates development and transformation via altering RNA processing
    Meeting Abstract

    Wang, M.; Ser, Z.; Rao, S.; Fahl, S.; Zhang, Y.; Peri, S.; Kentsis, A.; Wiest, D. L.
    Blood (2016)

    Fulltext@MSK | Save